Chongqing Pharscin Pharmaceutical Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Chongqing Pharscin Pharmaceutical has a total shareholder equity of CN¥1.7B and total debt of CN¥105.2K, which brings its debt-to-equity ratio to 0.01%. Its total assets and total liabilities are CN¥1.9B and CN¥254.4M respectively. Chongqing Pharscin Pharmaceutical's EBIT is CN¥66.1M making its interest coverage ratio -27. It has cash and short-term investments of CN¥471.9M.
Belangrijke informatie
0.006%
Verhouding schuld/eigen vermogen
CN¥105.16k
Schuld
| Rente dekkingsratio | -27x |
| Contant | CN¥471.87m |
| Aandelen | CN¥1.66b |
| Totaal verplichtingen | CN¥254.44m |
| Totaal activa | CN¥1.91b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 002907's short term assets (CN¥1.0B) exceed its short term liabilities (CN¥207.5M).
Langlopende schulden: 002907's short term assets (CN¥1.0B) exceed its long term liabilities (CN¥46.9M).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 002907 has more cash than its total debt.
Schuld verminderen: 002907's debt to equity ratio has reduced from 20.9% to 0.01% over the past 5 years.
Schuldendekking: 002907's debt is well covered by operating cash flow (138775.9%).
Rentedekking: 002907 earns more interest than it pays, so coverage of interest payments is not a concern.